The Relationship Between Tumor Size, Lymph Nodes, Metastasis, and Histopathological Stage Dr . Lamees Abdulraheem Nabat Cancer staging is an essential step in the diagnosis and management of malignant tumors. It provides information about the extent of disease and helps guide appropriate treatment. For many solid tumors, staging is based on the TNM system, which describes the primary tumor (T), regional lymph-node involvement (N), and distant metastasis (M). Medical imaging plays an important role in cancer staging. Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, and Positron Emission Tomography/Computed Tomography (PET/CT) can help determine the size and location of the primary tumor, its extension into surrounding tissues, regional lymph-node involvement, and the presence of distant metastases. Tumor size and local invasion are important factors in determining the T category. However, tumor size alone does not determine the overall stage of cancer. A relatively small tumor may have spread to lymph nodes or distant organs, while a larger tumor may remain localized. Assessment of regional lymph nodes is an important component of the N category. Imaging can identify suspicious lymph nodes based on their size, morphology, and metabolic activity. However, an enlarged or abnormal lymph node does not always indicate metastatic disease. Therefore, biopsy and histopathological examination may be required for definitive confirmation. The M category refers to distant metastasis. CT, MRI, PET/CT, and other imaging modalities can be used to detect the spread of cancer to organs such as the liver, lungs, bones, or brain, depending on the type of malignancy. The relationship between medical imaging and histopathology is particularly important in cancer staging. Imaging provides anatomical and functional information about the tumor and its distribution, while histopathological examination confirms the presence of malignant cells and provides microscopic information about tumor characteristics and grade. Consequently, clinical staging based on imaging and other clinical findings may differ from pathological staging, which incorporates histopathological results. Understanding the relationship between pathological changes and radiological appearance is particularly valuable for students of Radiologic Technology. It enables them to understand the pathological basis of abnormalities seen on medical images and strengthens their role within the multidisciplinary team involved in cancer diagnosis and management. Conclusion Medical imaging plays a vital role in cancer staging by evaluating the primary tumor, regional lymph nodes, and distant metastases. However, accurate staging requires integration of clinical, radiological, and histopathological findings. Collaboration among radiologists, pathologists, radiologic technologists, oncologists, surgeons, and other healthcare professionals is therefore essential for comprehensive cancer care.